Germline TP53 mutations, present in hereditary conditions such as Li-Fraumeni (LFS) and Li-Fraumeni-like (LFL) syndromes3, cause inherited cancer, while somatic TP53 mutations are associated with 5–50% of cases of every known cancer3. Here, TP53 is linked to Li-Fraumeni syndrome.